Related Experiment Video
Updated: Aug 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Antiretroviral drug therapy in HIV-infected Jamaican children
T Evans-Gilbert1, R Pierre, J C Steel-Duncan
1Kingston Paediatric and Perinatal HIV/AIDS Programme, Bustamante Hospital for Children, Jamaica.
Insights
Antiretroviral therapy (ART) improved health outcomes in HIV-infected Jamaican children, leading to weight gain and reduced hospitalizations. Access to affordable second-line ART is crucial for sustained treatment success.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Study focuses on HIV-infected Jamaican children undergoing antiretroviral therapy (ART).
- Reports on the outcomes of this cohort during a specific period.
Purpose of the Study:
- To evaluate the impact of ART on the health status of HIV-infected children in Jamaica.
- To assess changes in weight, height, hospital admissions, and length of stay post-ART initiation.
Main Methods:
- Observational prospective study design.
- Data collected on 110 HIV-infected children from 2001-2003.
- Outcome measures compared at ART initiation and within six months.
Main Results:
- Significant improvements observed: mean weight gain of 2.8 kg and height gain of 1.7 cm.
- Reduced hospital admissions by an average of 1.5 and length of stay by 12.9 days.
- Most children were severely symptomatic (CDC class C) at baseline; 36% had CD4 counts available.
Conclusions:
- ART introduction led to improved health outcomes in Jamaican children with HIV.
- ART initiation occurred in older children, often cared for at home.
- Challenges with accessing affordable second-line ART highlight the importance of adherence to first-line therapy.
Background:
The study describes a cohort of HIV-infected Jamaican children receiving antiretroviral therapy (ART) and reports the outcome.
Method:
An observational prospective study was conducted on HIV-infected Jamaican children receiving anti retroviral drug therapy (ART). The outcome measures, weight, height, hospital admissions and length of stay were compared at initiation and within six months of commencing ART.
Results:
There were 37 (33.6%) of 110 HIV-infected children receiving ART during 2001 to 2003. The median age at commencement was six years (age range 1-16 years) with 54.1% (20) males and 48% AIDS orphans. Care was home-based for 68 % of all cases with the University Hospital of the West Indies managing 27 (73%) and the Bustamante Hospital for Children 10 (27%). The distribution by Centers for Disease Control and Prevention (CDC) clinical class was C (severely symptomatic), 22 (59.5%); B (moderately symptomatic), 8 (21.6%); A (mildly symptomatic), 6 (16.2%) and N (asymptomatic), one (2.7%). Among 14 (36%) children with CD4 counts, 8 (57%) were CDC immune class 2 (moderate immunodeficiency) and 6 (43%) were class 3 (severe immunodeficiency). After commencing ART the mean difference in admissions was--1.5+/-2.55 admissions (95% CI -2.3, -0.6; p < 0.001) and in length of stay was -12.9+/-21 day (95% CI -19.9, -0.5.9; p < 0.001). Antiretroviral therapy resulted in a mean weight gain of 2.8 kg+/-4.9 kg (95% CI 1.0, 4.5; p < 0.003) and a mean gain in height of 1.7 cm+/-2.6 cm (95% CI 0.6, 2.8; p < 0.003). Five children required second line therapy.
Conclusion:
The introduction of antiretroviral therapy has resulted in improved outcomes and is being initiated in older children cared for mainly at home. Limitations in accessing affordable second line agents underscore the need for compliance with first line therapy.
Related Concept Videos
Retrovirus Life Cycles
Antiviral Nucleoside Inhibitors
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Subviral Agents
Antiprotozoal Agents

